Patterns of loss of heterozygosity at 10q23.3 and microsatellite instability in endometriosis, atypical endometriosis, and ovarian carcinoma arising in association with endometriosis
- PMID: 16810057
- DOI: 10.1097/01.pgp.0000192274.44061.36
Patterns of loss of heterozygosity at 10q23.3 and microsatellite instability in endometriosis, atypical endometriosis, and ovarian carcinoma arising in association with endometriosis
Abstract
Genetic aberrations, such as loss of heterozygosity (LOH) and mutations leading to functional inactivation of the PTEN tumor suppressor gene, located on chromosome 10q23.3, have been shown to be associated with approximately one third of ovarian adenocarcinomas. In addition, microsatellite instability (MSI) leading to the functional inactivation of the PTEN gene has also been reported for ovarian adenocarcinomas with frequencies varying from 6 to 37%. However, the frequency of PTEN gene abnormalities has not been well studied or evaluated in lesions such as typical and atypical endometriosis. The aim of this study was to investigate a possible sequential progression from endometriosis through atypical endometriosis to ovarian carcinoma by assessing LOH at 10q23.3 and MSI in those entities. Genomic DNA was analyzed for LOH and MSI at 3 loci on chromosome 10, using polymerase chain reaction amplification. Significant differences in LOH were seen between endometriosis (4.3%) and ovarian carcinoma (23.5%) at D10S608. The differences at the other 2 loci were not significant. A high frequency of MSI was found in endometriosis (82.6%) and atypical endometriosis (75%); however, the differences were not significant. These results suggest that LOH at D105608 may possibly be an important molecular event in the progression of endometriosis to carcinoma. This study highlights that endometriosis and atypical endometriosis might act as precursor lesions that have the potential to progress into ovarian adenocarcinoma.
Similar articles
-
Loss of heterozygosity on 10q23.3 and mutation of the tumor suppressor gene PTEN in benign endometrial cyst of the ovary: possible sequence progression from benign endometrial cyst to endometrioid carcinoma and clear cell carcinoma of the ovary.Cancer Res. 2000 Dec 15;60(24):7052-6. Cancer Res. 2000. PMID: 11156411
-
Microsatellite analysis of endometriosis reveals loss of heterozygosity at candidate ovarian tumor suppressor gene loci.Cancer Res. 1996 Aug 1;56(15):3534-9. Cancer Res. 1996. PMID: 8758923
-
Possible involvement of loss of heterozygosity in malignant transformation of ovarian endometriosis.Gynecol Oncol. 2011 Feb;120(2):239-46. doi: 10.1016/j.ygyno.2010.10.036. Epub 2010 Dec 3. Gynecol Oncol. 2011. PMID: 21130491
-
Molecular pathogenesis of endometriosis-associated clear cell carcinoma of the ovary (review).Oncol Rep. 2009 Aug;22(2):233-40. Oncol Rep. 2009. PMID: 19578761 Review.
-
The association between endometriosis and ovarian cancer: a review of histological, genetic and molecular alterations.Gynecol Oncol. 2012 Jan;124(1):164-9. doi: 10.1016/j.ygyno.2011.10.001. Epub 2011 Oct 26. Gynecol Oncol. 2012. PMID: 22032835 Review.
Cited by
-
Serial analysis of gene expression reveals differential expression between endometriosis and normal endometrium. Possible roles for AXL and SHC1 in the pathogenesis of endometriosis.Reprod Biol Endocrinol. 2008 Dec 2;6:59. doi: 10.1186/1477-7827-6-59. Reprod Biol Endocrinol. 2008. PMID: 19055724 Free PMC article.
-
Endometriosis research using capture microdissection techniques: Progress and future applications.Biomed Rep. 2016 Nov;5(5):531-540. doi: 10.3892/br.2016.758. Epub 2016 Sep 15. Biomed Rep. 2016. PMID: 27882213 Free PMC article.
-
New Evidence About Malignant Transformation of Endometriosis-A Systematic Review.J Clin Med. 2025 Apr 25;14(9):2975. doi: 10.3390/jcm14092975. J Clin Med. 2025. PMID: 40364006 Free PMC article. Review.
-
Ovarian Endometrioid and Clear Cell Carcinomas with Low Prevalence of Microsatellite Instability: A Unique Subset of Ovarian Carcinomas Could Benefit from Combination Therapy with Immune Checkpoint Inhibitors and Other Anticancer Agents.Healthcare (Basel). 2022 Apr 7;10(4):694. doi: 10.3390/healthcare10040694. Healthcare (Basel). 2022. PMID: 35455871 Free PMC article.
-
Genome profiling of ovarian adenocarcinomas using pangenomic BACs microarray comparative genomic hybridization.Mol Cytogenet. 2008 May 20;1:10. doi: 10.1186/1755-8166-1-10. Mol Cytogenet. 2008. PMID: 18492273 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials